Comparative study with intestinal preparation 1 L Peg + Asc with 4 L gold standard, both in split dose.

Phase 1

• Conditions: Screening or surveillance or diagnostic colonoscopy.; MedDRA version: 21.0Level: PTClassification code 10010011Term: Colonoscopy normalSystem Organ Class: 10022891 - Investigations; Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

• Registration Number: EUCTR2018-004543-24-IT
• Lead Sponsor: Provincia Religiosa di S.Pietro Ordine Ospedaliero San Giovanni di Dio Fatebenefratelli

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-06
• Last Update Posted: 2 March 2022

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Patients aged =18 aa and =85aa will be enrolled, who must undergo a screening, surveillance or diagnostic colonoscopy, capable of taking the preparation, without contraindications to the intake of the active ingredients of the two preparations.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 300
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

Patients under the age of 18 or over 85 years, pregnant women, patients unable to take the preparation, or with contraindications to taking the active ingredients of the two preparations

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified